Recent Patents on Anti-Infective Drug Discovery
Volume 15, 3 Issues, 2020
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Recent Patents on Anti-Infective Drug Discovery, Volume 9 - Number 2
Recent Developments in Anti-dotes Against Anthrax
, 9(2): 83 - 96Neha Dhasmana, Lalit K. Singh, Asani Bhaduri, Richa Misra and Yogendra Singh
DOI: 10.2174/1574891X09666140830213925
Recent Developments in Anti-dotes Against Anthrax
Current Status of Chemically Synthesized Inhibitors of Ebola Virus
, 9(2): 97 - 103Anthony P. Cardile, Douglas L. Mayers and Sina Bavari
DOI: 10.2174/1574891X10666150326114221
Current Status of Chemically Synthesized Inhibitors of Ebola Virus
Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
, 9(2): 104 - 111Rashi Chauhan, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain
DOI: 10.2174/1574891X09666141114222644
Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
New Perspectives of HIV/AIDS Therapy Study
, 9(2): 112 - 120Da-Yong Lu, Ting-Ren Lu, Jin-Yu Che, Hong-Ying Wu and Bin Xu
DOI: 10.2174/1574891X10666150109115402
New Perspectives of HIV/AIDS Therapy Study
Cancer Targeted Magic Bullets for Effective Treatment of Cancer
, 9(2): 121 - 135Preeti Aneja, Mahfoozur Rahman, Sarwar Beg, Shivali Aneja, Vishal Dhingra and Rupali Chugh
DOI: 10.2174/1574891X10666150415120506
Cancer Targeted Magic Bullets for Effective Treatment of Cancer
Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
, 9(2): 136 - 143Sasmita Biswal
DOI: 10.2174/1574891X10666150408153356
Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
Evaluation of Urinary Interleukin-8 Levels in Patients with Spinal Cord Injury
, 9(2): 144 - 149Monireh Rahimkhani, Alireza Mordadi, Sajad Varmazyar and Ali Tavakoli
DOI: 10.2174/1574891X10666150310152532
Opinion Paper: Pharmacogenomics Testing for Type B Adverse Drug Reactions to Anti- Infective Drugs: The Example of Hypersensitivity to Abacavir
, 9(2): 151José A.G. Agúndez, Gara Esguevillas, Gemma Amo and Elena García-Martín
DOI: 10.2174/1574891X10666150416130637
Editor-in-Chief
Tianhong Dai
Massachusetts General Hospital
Harvard Medical School
Boston, MA
(USA)
Biography
Massachusetts General Hospital
Harvard Medical School
Boston, MA
Biography
Biography of Tianhong Dai
Tianhong Dai is an assistant professor with the Harvard Medical School. He is considered a world leader in antimicrobial blue light therapy for infections, and a world expert in animal models of wound infections using bioluminescent microbes. He is the author and coauthor of more than 80 peer-reviewed publications. Dr. Dai’s research has been supported by the NIH (R01 and R21), DoD and other funding sources.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Tianhong Dai serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.10
New eBook
 |
Frontiers in Clinical Drug Research-Anti InfectivesYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net